EUVIMEDEUVIMED entdecken
Crossref

Inotodiol ameliorates the progression of osteoarthritis: An in vitro and in vivo study

Wanfeng Qian, Ruheng Ji, Qiujie Ye, Wenjun Hu, Linying Zhou, Hongwu Pan, Xiaoming Li

Drug Research · 01.11.2023 · 73 (09) · 506-512

DOI: 10.1055/a-2176-4098 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Research, erschienen am 01.11.2023. Verfasst von Wanfeng Qian und 6 weiteren Autor:innen. Beteiligte Einrichtung: Affiliated Hospital of Shaoxing University of Arts and Sciences. Hauptthemen laut MEDLINE: Lanosterol, Osteoarthritis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 22 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Osteoarthritis is a common chronic degenerative disease, of which the essence is the degenerative changes of bone and joint cartilage, involving damage in multiple structures such as bone, synovium and joints. In the mechanism of arthritis inflammation is closely related, and therefore the exploration to inhibit inflammatory mediators is crucial for the clinical prevention and treatment of osteoarthritis. Inotodiol is a lanostane triterpenoid isolated from Inonotus obliquus, which had been extensively reported to be an anti-inflammatory agent, but its effect on arthritis remains unknown. In this study, we firstly demonstrated that inotodiol significantly reduced IL-1β-induced chondrocyte injury and inhibited the release of inflammatory factors. At the same time, experiments in vivo showed that inotodiol could effectively improve the symptoms of joint injury in mice and reduce the area of cartilage destruction, indicating that inotodiol may be a potential therapeutic drug for osteoarthritis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LanosterolOsteoarthritisMiceAnimalsInflammationAnti-Inflammatory Agents

Substanzen

inotodiolLanosterolAnti-Inflammatory Agents

Autor:innen und Institutionen

  • Affiliated Hospital of Shaoxing University of Arts and Sciences.
  • The first People's Hospital of Guannan County, Jiangsu, China.
  • Department of Orthopaedics, 72nd Group Army Hospital, Huzhou University, Huzhou, Zhejiang, China.

Zitieren

APA

Qian, W., Ji, R., Ye, Q., Hu, W., Zhou, L., Pan, H., & Li, X. (2023). Inotodiol ameliorates the progression of osteoarthritis: An in vitro and in vivo study. Drug Research, 73(09), 506-512. https://doi.org/10.1055/a-2176-4098

Vancouver

Qian W, Ji R, Ye Q, Hu W, Zhou L, Pan H, et al. Inotodiol ameliorates the progression of osteoarthritis: An in vitro and in vivo study. Drug Research. 2023;73(09):506-512. doi:10.1055/a-2176-4098

BibTeX
@article{Qian2023,
  author = {Qian, Wanfeng and Ji, Ruheng and Ye, Qiujie and Hu, Wenjun and Zhou, Linying and Pan, Hongwu and Li, Xiaoming},
  title = {Inotodiol ameliorates the progression of osteoarthritis: An in vitro and in vivo study},
  journal = {Drug Research},
  year = {2023},
  volume = {73},
  number = {09},
  pages = {506--512},
  doi = {10.1055/a-2176-4098}
}
Kostenlos starten →